Highlights from HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Italian Hospital of Buenos Aires, Buenos Aires (Argentina)
3 More presentations in this session
Doctor A. Salvati (Moron, Buenos Aires, AR)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
Congress Presentation
